Publication:
Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias

Simple item page
dc.contributor.authorWai Cheng Foongen_US
dc.contributor.authorJacqueline J. Hoen_US
dc.contributor.authorC. Khai Lohen_US
dc.contributor.authorVip Viprakasiten_US
dc.contributor.otherPenang Medical Collegeen_US
dc.contributor.otherUniversiti Kebangsaan Malaysiaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-23T10:48:32Z
dc.date.available2018-11-23T10:48:32Z
dc.date.issued2015-03-16en_US
dc.description.abstract© 2015 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of hydroxyurea in people with NTDßT (HbE/ß thalassaemia and ß thalassaemia intermedia).en_US
dc.identifier.citationCochrane Database of Systematic Reviews. Vol.2015, No.3 (2015)en_US
dc.identifier.doi10.1002/14651858.CD011579en_US
dc.identifier.issn1469493Xen_US
dc.identifier.other2-s2.0-85042053916en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36488
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042053916&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleHydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemiasen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042053916&origin=inwarden_US

Files

Collections

Scopus 2011-2015